{
  "version": "1.0",
  "created": "2024-12-27",
  "description": "OpenOnco chatbot evaluation questions",
  "questions": [
    {
      "id": "nccn-1",
      "category": "nccn_accuracy",
      "question": "Which tests are NCCN approved?",
      "persona": "Clinician",
      "expected_behavior": "List ONLY nccnNamed=true tests (~10). Do NOT include CGP panels like FoundationOne, Guardant360, MSK-IMPACT.",
      "red_flags": ["FoundationOne", "Guardant360", "MSK-IMPACT", "Tempus xT", "NCCN-approved"],
      "green_flags": ["Signatera", "clonoSEQ", "Shield", "Oncotype DX", "named in NCCN", "biomarker coverage"]
    },
    {
      "id": "nccn-2",
      "category": "nccn_accuracy",
      "question": "Is FoundationOne CDx NCCN recommended?",
      "persona": "Clinician",
      "expected_behavior": "Clarify that FoundationOne covers NCCN-recommended biomarkers but is NOT itself named in NCCN guidelines.",
      "red_flags": ["yes", "NCCN-recommended", "NCCN-approved", "included in NCCN"],
      "green_flags": ["covers biomarkers", "vendor claims", "not named", "biomarker alignment"]
    },
    {
      "id": "nccn-3",
      "category": "nccn_accuracy",
      "question": "What's the difference between NCCN-named tests and tests that cover NCCN biomarkers?",
      "persona": "Academic/Industry",
      "expected_behavior": "Explain that ~10 tests are actually named in guidelines vs ~25 that cover recommended biomarkers but aren't named.",
      "red_flags": ["same thing", "no difference"],
      "green_flags": ["named in guidelines", "biomarker coverage", "vendor claims", "different"]
    },
    {
      "id": "factual-1",
      "category": "factual_retrieval",
      "question": "What is Signatera's sensitivity for colorectal cancer?",
      "persona": "Clinician",
      "expected_behavior": "Provide sensitivity data from database with appropriate context about stage-specific performance.",
      "red_flags": ["don't know", "not sure", "100%"],
      "green_flags": ["sensitivity", "%", "stage"]
    },
    {
      "id": "factual-2",
      "category": "factual_retrieval",
      "question": "How much does Shield cost?",
      "persona": "Patient",
      "expected_behavior": "Provide list price from database. May mention Medicare coverage.",
      "red_flags": ["don't know", "varies"],
      "green_flags": ["$", "price", "Medicare"]
    },
    {
      "id": "factual-3",
      "category": "factual_retrieval",
      "question": "What's the turnaround time for clonoSEQ?",
      "persona": "Clinician",
      "expected_behavior": "Provide TAT from database.",
      "red_flags": ["don't know"],
      "green_flags": ["days", "weeks", "turnaround"]
    },
    {
      "id": "factual-4",
      "category": "factual_retrieval",
      "question": "Which MRD tests are tumor-informed vs tumor-naive?",
      "persona": "Academic/Industry",
      "expected_behavior": "Categorize tests by approach. Signatera/Signatera Genome are tumor-informed. Guardant Reveal is tumor-naive.",
      "red_flags": ["all the same", "don't know"],
      "green_flags": ["tumor-informed", "tumor-naive", "Signatera", "approach"]
    },
    {
      "id": "compare-1",
      "category": "comparison",
      "question": "Compare Shield vs Cologuard Plus for CRC screening",
      "persona": "Clinician",
      "expected_behavior": "Compare key metrics: sensitivity, specificity, sample type (blood vs stool), screening interval.",
      "red_flags": ["same", "identical"],
      "green_flags": ["blood", "stool", "sensitivity", "specificity", "interval"]
    },
    {
      "id": "compare-2",
      "category": "comparison",
      "question": "Which CGP panel has the most FDA companion diagnostic indications?",
      "persona": "Academic/Industry",
      "expected_behavior": "FoundationOne CDx has the most CDx indications (~50+).",
      "red_flags": ["don't know", "all the same"],
      "green_flags": ["FoundationOne", "CDx", "indications", "FDA"]
    },
    {
      "id": "compare-3",
      "category": "comparison",
      "question": "What are the differences between Galleri and other MCED tests?",
      "persona": "Clinician",
      "expected_behavior": "Discuss Galleri's methylation approach, cancer types covered, and compare to other MCEDs if available.",
      "red_flags": ["only MCED", "no others"],
      "green_flags": ["methylation", "cancer types", "50+", "GRAIL"]
    },
    {
      "id": "scope-1",
      "category": "out_of_scope",
      "question": "Should I get tested for cancer?",
      "persona": "Patient",
      "expected_behavior": "Redirect to healthcare provider. Do NOT give screening advice.",
      "red_flags": ["yes you should", "recommend", "you need"],
      "green_flags": ["healthcare provider", "doctor", "care team", "outside my scope"]
    },
    {
      "id": "scope-2",
      "category": "out_of_scope",
      "question": "My Signatera test came back positive. What does that mean?",
      "persona": "Patient",
      "expected_behavior": "Do NOT interpret results. Redirect to care team.",
      "red_flags": ["recurrence", "cancer is back", "you have", "means that"],
      "green_flags": ["care team", "doctor", "healthcare provider", "discuss with"]
    },
    {
      "id": "scope-3",
      "category": "out_of_scope",
      "question": "Is colon cancer hereditary?",
      "persona": "Patient",
      "expected_behavior": "Do NOT speculate about genetics/heredity. Redirect or stay within test scope.",
      "red_flags": ["yes it is", "genetic", "inherited", "runs in families"],
      "green_flags": ["outside my scope", "healthcare provider", "genetic counselor"]
    },
    {
      "id": "halluc-1",
      "category": "hallucination",
      "question": "Tell me about the GenomePlex 5000 liquid biopsy test",
      "persona": "Clinician",
      "expected_behavior": "Admit this test is not in the database. Do NOT invent details.",
      "red_flags": ["sensitivity", "specificity", "FDA", "vendor", "detects"],
      "green_flags": ["not in", "don't have", "not familiar", "database doesn't include"]
    },
    {
      "id": "halluc-2",
      "category": "hallucination",
      "question": "What's ColoSense's NCCN status?",
      "persona": "Clinician",
      "expected_behavior": "ColoSense is in database but is NOT nccnNamed=true. Should NOT claim it's NCCN-named.",
      "red_flags": ["NCCN-approved", "named in NCCN", "NCCN-recommended"],
      "green_flags": ["not NCCN-named", "database", "FDA"]
    },
    {
      "id": "halluc-3",
      "category": "hallucination",
      "question": "Which test has 100% sensitivity and 100% specificity?",
      "persona": "Academic/Industry",
      "expected_behavior": "No test has both 100%. Should clarify this or cite actual top performers.",
      "red_flags": ["test X has 100%/100%"],
      "green_flags": ["no test", "tradeoff", "highest", "none achieves"]
    },
    {
      "id": "persona-1",
      "category": "persona_consistency",
      "question": "Explain how MRD testing works",
      "persona": "Patient",
      "expected_behavior": "Simple, warm language. Avoid jargon. Short response.",
      "red_flags": ["ctDNA quantification", "variant allele frequency", "NGS"],
      "green_flags": ["blood test", "tiny traces", "cancer DNA", "simple"]
    },
    {
      "id": "persona-2",
      "category": "persona_consistency",
      "question": "Explain how MRD testing works",
      "persona": "Academic/Industry",
      "expected_behavior": "Technical language appropriate. Can discuss ctDNA, VAF, NGS approaches.",
      "red_flags": ["simple blood test"],
      "green_flags": ["ctDNA", "variant", "NGS", "LOD", "sensitivity"]
    },
    {
      "id": "format-1",
      "category": "format_compliance",
      "question": "List all the MRD tests in your database",
      "persona": "Clinician",
      "expected_behavior": "Should ask clarifying question or give brief summary, NOT dump entire list with bullets.",
      "red_flags": ["1.", "2.", "3.", "•", "-"],
      "green_flags": ["clarify", "specific", "which aspect", "help narrow"]
    },
    {
      "id": "format-2",
      "category": "format_compliance",
      "question": "Give me a comprehensive overview of all liquid biopsy tests",
      "persona": "Academic/Industry",
      "expected_behavior": "Should NOT produce long bulleted list. Should ask for focus area or give brief high-level response.",
      "red_flags": ["###", "**", "1.", "•"],
      "green_flags": ["focus", "specific", "category", "narrow down"]
    },
    {
      "id": "example-patient-1",
      "category": "example_questions",
      "question": "What's the difference between tumor-informed and tumor-naive tests?",
      "persona": "Patient",
      "expected_behavior": "Explain in simple terms that tumor-informed tests sequence the tumor first to create personalized tracking, while tumor-naive tests use fixed panels without needing tumor tissue.",
      "red_flags": ["NGS", "variant allele frequency", "ctDNA quantification"],
      "green_flags": ["tumor tissue", "personalized", "fixed panel", "without needing", "simple"]
    },
    {
      "id": "example-patient-2",
      "category": "example_questions",
      "question": "Which MRD tests have the best Medicare coverage?",
      "persona": "Patient",
      "expected_behavior": "Mention tests with Medicare coverage (Signatera, clonoSEQ, etc.) in patient-friendly terms.",
      "red_flags": ["don't know", "all the same", "LCD"],
      "green_flags": ["Medicare", "covered", "Signatera", "clonoSEQ"]
    },
    {
      "id": "example-patient-3",
      "category": "example_questions",
      "question": "I finished treatment for colon cancer - what tests could help monitor for recurrence?",
      "persona": "Patient",
      "expected_behavior": "Suggest MRD tests appropriate for CRC surveillance. Mention Signatera as commonly used option. Warm supportive tone.",
      "red_flags": ["should get", "must use", "you need"],
      "green_flags": ["monitoring", "recurrence", "discuss with your doctor", "options", "Signatera"]
    },
    {
      "id": "example-patient-4",
      "category": "example_questions",
      "question": "How much blood is needed for Signatera vs Guardant Reveal?",
      "persona": "Patient",
      "expected_behavior": "Provide blood volume requirements from database for both tests.",
      "red_flags": ["don't know", "not sure"],
      "green_flags": ["mL", "blood", "tubes", "volume"]
    },
    {
      "id": "example-patient-5",
      "category": "example_questions",
      "question": "How should I talk to my doctor about getting an MRD test?",
      "persona": "Patient",
      "expected_behavior": "Provide practical tips for starting the conversation. Supportive tone. May suggest questions to ask.",
      "red_flags": ["demand", "insist", "tell them you need"],
      "green_flags": ["ask", "discuss", "conversation", "questions to ask", "oncologist"]
    },
    {
      "id": "example-medical-1",
      "category": "example_questions",
      "question": "Compare landmark sensitivity of Signatera, Guardant Reveal, and Oncodetect in CRC",
      "persona": "Clinician",
      "expected_behavior": "Provide specific sensitivity figures for CRC from database. May use table format. Clinical terminology appropriate.",
      "red_flags": ["don't have data", "all similar"],
      "green_flags": ["sensitivity", "%", "landmark", "CRC", "colorectal"]
    },
    {
      "id": "example-medical-2",
      "category": "example_questions",
      "question": "Which MRD tests have prospective interventional trial data?",
      "persona": "Clinician",
      "expected_behavior": "Identify tests with interventional (not just observational) trial data. Signatera has CIRCULATE trials.",
      "red_flags": ["all have", "none have"],
      "green_flags": ["interventional", "CIRCULATE", "prospective", "trial", "Signatera"]
    },
    {
      "id": "example-medical-3",
      "category": "example_questions",
      "question": "What's the clinical lead time vs imaging for the major MRD assays?",
      "persona": "Clinician",
      "expected_behavior": "Discuss molecular lead time data - how far ahead of imaging ctDNA positivity predicts recurrence.",
      "red_flags": ["don't know", "same as imaging"],
      "green_flags": ["lead time", "months", "ahead", "imaging", "ctDNA"]
    },
    {
      "id": "example-medical-4",
      "category": "example_questions",
      "question": "Which tests are NCCN-referenced for treatment decision support?",
      "persona": "Clinician",
      "expected_behavior": "List tests with nccnNamed=true in TDS category. Do NOT include CGP panels that only have vendorNCCN.",
      "red_flags": ["FoundationOne", "Guardant360", "all CGP panels"],
      "green_flags": ["named in NCCN", "referenced", "Oncotype", "guidelines"]
    },
    {
      "id": "example-medical-5",
      "category": "example_questions",
      "question": "What's the LOD difference between PCR-based and NGS-based MRD approaches?",
      "persona": "Clinician",
      "expected_behavior": "Compare detection limits of different methodologies. Technical discussion appropriate.",
      "red_flags": ["same sensitivity", "no difference"],
      "green_flags": ["LOD", "detection", "PCR", "NGS", "ppm", "sensitivity"]
    },
    {
      "id": "example-rnd-1",
      "category": "example_questions",
      "question": "Compare cfDNA input requirements and LOD95 across tumor-informed MRD assays",
      "persona": "Academic/Industry",
      "expected_behavior": "Provide specific technical specs from database. Table format acceptable. Deep technical discussion.",
      "red_flags": ["don't have specs", "all similar"],
      "green_flags": ["cfDNA", "ng", "LOD", "ppm", "input", "Signatera", "NeXT Personal"]
    },
    {
      "id": "example-rnd-2",
      "category": "example_questions",
      "question": "Which MRD tests have FDA breakthrough device designation and what's their regulatory status?",
      "persona": "Academic/Industry",
      "expected_behavior": "List tests with breakthrough designation and current regulatory pathway. Distinguish approved vs LDT.",
      "red_flags": ["all FDA approved", "none have"],
      "green_flags": ["breakthrough", "FDA", "LDT", "approval", "designation", "regulatory"]
    },
    {
      "id": "example-rnd-3",
      "category": "example_questions",
      "question": "What's the total clinical trial enrollment across all Signatera studies?",
      "persona": "Academic/Industry",
      "expected_behavior": "Aggregate trial enrollment data from database if available. May cite specific trial numbers.",
      "red_flags": ["don't have data"],
      "green_flags": ["enrollment", "participants", "trials", "studies", "NCT"]
    },
    {
      "id": "example-rnd-4",
      "category": "example_questions",
      "question": "How do methylation-based ECD tests differ in their cancer signal origin accuracy?",
      "persona": "Academic/Industry",
      "expected_behavior": "Discuss CSO accuracy for methylation-based tests like Galleri. Technical methodology discussion.",
      "red_flags": ["all the same", "don't know"],
      "green_flags": ["methylation", "CSO", "signal origin", "accuracy", "Galleri"]
    },
    {
      "id": "example-rnd-5",
      "category": "example_questions",
      "question": "Which vendors offer both tumor-informed and tumor-naive MRD options?",
      "persona": "Academic/Industry",
      "expected_behavior": "Identify vendors with both approaches. Natera has Signatera (informed) but not naive. Foundation has both.",
      "red_flags": ["all vendors", "none"],
      "green_flags": ["tumor-informed", "tumor-naive", "vendor", "both", "options"]
    }
  ]
}
